Literature DB >> 33446182

Bushen Huoxue recipe attenuates early pregnancy loss via activating endometrial COX2-PGE2 angiogenic signaling in mice.

Yufan Song1, Fanru Zhou1, Xiujuan Tan1, Xia Liu1, Jiahui Ding2, Chu Zhang1, Fan Li1, Wenxin Zhu1, Wenwen Ma1, Runan Hu1, Mingmin Zhang3.   

Abstract

BACKGROUND: During the fresh cycles of in vitro fertilization and embryo transfer, a disturbance in the reproductive endocrine environment following controlled ovarian hyperstimulation (COH) is closely related to compromised endometrial receptivity. This is a major disadvantage for women during pregnancy. Based on the theory of traditional Chinese medicine, Bushen Huoxue recipe (BSHXR) has been indicated to facilitate embryo implantation.
METHODS: The COH model (Kunming breed) was induced by injecting mice with pregnant mare serum gonadotrophin (0.4 IU/g) and human chorionic gonadotropin (1 IU/g), followed by treatment with BSHXR at three different concentrations (5.7, 11.4, and 22.8 g/kg), Bushen recipe (BSR) (5.7 g/kg), and Huoxue recipe (HXR) (5.7 g/kg). After successful mating, the pregnancy rate and implantation sites were examined on embryo day 8 (ED8), and the weight ratio of endometrium was calculated on ED4 midnight. Serum estrogen, progesterone, and endometrial PGE2 levels were measured using enzyme-linked immunosorbent assay. The endometrial microvasculature was evaluated using CD31 immunostaining. The protein and mRNA levels of the angiogenic factors in the endometrium were evaluated using western blot, immunohistochemistry, and polymerase chain reaction.
RESULTS: In the COH group, the pregnancy rate and implantation sites were significantly decreased, and abnormal serum hormone levels and impaired endometrial vascular development were observed. After BSHXR treatment, the supraphysiological serum progesterone level in COH mice was restored to normalcy. Moreover, the abnormal expression of the endometrial pro-angiogenic factors, including HIF1α, COX2-PGE2 pathway, and the down-stream factors, namely, MMP2, MMP9, TIMP2, and FGF2 after subjecting mice to COH was significantly improved after BSHXR treatment.
CONCLUSION: BSHXR could improve embryo implantation by regulating hormonal balance and modulating endometrial angiogenesis in mice, without inducing any side effects in normal pregnancy.

Entities:  

Keywords:  Bushen Huoxue recipe; Early pregnancy loss; Endometrial angiogenesis; Hormone balance; Traditional Chinese medicine

Year:  2021        PMID: 33446182     DOI: 10.1186/s12906-021-03201-9

Source DB:  PubMed          Journal:  BMC Complement Med Ther        ISSN: 2662-7671


  50 in total

1.  Molecular interactions between embryo and uterus in the adhesion phase of human implantation.

Authors:  C Simón; C Moreno; J Remohí; A Pellicer
Journal:  Hum Reprod       Date:  1998-06       Impact factor: 6.918

Review 2.  The endometrium during and after ovarian hyperstimulation and the role of segmentation of infertility treatment.

Authors:  Pedro Montoya-Botero; Nikolaos P Polyzos
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2018-09-13       Impact factor: 4.690

3.  Endometrial injury increases expression of hypoxia-inducible factor and angiogenesis in the endometrium of women with recurrent implantation failure.

Authors:  Xuan Yu; Cong Gao; Caifeng Dai; Fang Yang; Xiaohui Deng
Journal:  Reprod Biomed Online       Date:  2018-12-22       Impact factor: 3.828

Review 4.  Clinical approach to recurrent implantation failure: evidence-based evaluation of the endometrium.

Authors:  Harvey J Kliman; David Frankfurter
Journal:  Fertil Steril       Date:  2019-04       Impact factor: 7.329

5.  Sirolimus as a new drug to treat RIF patients with elevated Th17/Treg ratio: A double-blind, phase II randomized clinical trial.

Authors:  Majid Ahmadi; Samaneh Abdolmohamadi-Vahid; Mahnaz Ghaebi; Sanam Dolati; Sanaz Abbaspour-Aghdam; Shahla Danaii; Katayoun Berjis; Rahime Madadi-Javid; Zahra Nouri; Homayoon Siahmansouri; Zohreh Babaloo; Mohammad Nouri; Mehdi Yousefi
Journal:  Int Immunopharmacol       Date:  2019-07-09       Impact factor: 4.932

Review 6.  International disparities in access to infertility services.

Authors:  Robert D Nachtigall
Journal:  Fertil Steril       Date:  2006-04       Impact factor: 7.329

Review 7.  Mechanisms of implantation: strategies for successful pregnancy.

Authors:  Jeeyeon Cha; Xiaofei Sun; Sudhansu K Dey
Journal:  Nat Med       Date:  2012-12       Impact factor: 53.440

8.  A comparison of the effects of three luteal phase support protocols with estrogen on in vitro fertilization-embryo transfer outcomes in patients on a GnRH antagonist protocol.

Authors:  Juliano Brum Scheffer; Bruno Brum Scheffer; Rafaela Friche de Carvalho; Ana Paula Aguiar; Daniel H Mendez Lozano; Julie Labrosse; Michael Grynberg
Journal:  JBRA Assist Reprod       Date:  2019-08-22

Review 9.  Uterine receptivity, embryo attachment, and embryo invasion: Multistep processes in embryo implantation.

Authors:  Yamato Fukui; Yasushi Hirota; Mitsunori Matsuo; Mona Gebril; Shun Akaeda; Takehiro Hiraoka; Yutaka Osuga
Journal:  Reprod Med Biol       Date:  2019-05-24

Review 10.  Infertility and the provision of infertility medical services in developing countries.

Authors:  Willem Ombelet; Ian Cooke; Silke Dyer; Gamal Serour; Paul Devroey
Journal:  Hum Reprod Update       Date:  2008-09-26       Impact factor: 15.610

View more
  2 in total

1.  BushenHuoxue Recipe for the Treatment of Prethrombotic State of ACA-Positive Recurrent Miscarriage via the Regulation of the PI3K-AKT Signaling Pathway.

Authors:  Xuan Yang; Shulan Su; Qingling Ren; Lijing Liu; Jiashang Li; Wen Zhang; Ke Cai; Zhuo Xu; Xin Pan
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-14       Impact factor: 2.629

Review 2.  The Treatment of Complementary and Alternative Medicine on Female Infertility Caused by Endometrial Factors.

Authors:  Jing Lin; Haoyue Ma; Hang Li; Jing Han; Tingting Guo; Zhen Qin; Liyan Jia; Yuehui Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-07       Impact factor: 2.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.